The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol

The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol

The coronavirus disease 2019 (COVID-19), a pneumonia caused by a novel coronavirus, was reported in December 2019. COVID-19 is highly contagious and has rapidly developed from a regional epidemic into a global pandemic. As yet, no effective drugs have been found to treat this virus. This study, an o...

Full description

Bibliographic Details
Main Authors: Xiaoke Wu, Kaijiang Yu, Yongchen Wang, Wanhai Xu, Hongli Ma, Yan Hou, Yue Li, Benzhi Cai, Liying Zhu, Min Zhang, Xiaoli Hu, Jingshu Gao, Yu Wang, Huichao Qin, Mingyan Zhao, Yong Zhang, Kang Li, Zhimin Du, Baofeng Yang
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Engineering
Subjects:
Coronavirus disease 2019
Pneumonia
SARS-CoV-2
Triazavirin
Efficacy
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S2095809920301697

Internet

http://www.sciencedirect.com/science/article/pii/S2095809920301697

Similar Items